[Effect of astaxanthin on preeclampsia rat model]

Area of Science:

• Biomedical Science
• Pharmacology
• Reproductive Biology

Background:

• Preeclampsia is a serious pregnancy complication characterized by hypertension and proteinuria.
• N(Ω)-nitro-L-arginine methyl ester (L-NAME) is a common agent used to induce preeclampsia-like symptoms in animal models.
• Oxidative stress and inflammation play critical roles in the pathogenesis of preeclampsia.

Purpose of the Study:

• To investigate the therapeutic potential of astaxanthin in a rat model of L-NAME induced preeclampsia.
• To evaluate the effects of astaxanthin on key biomarkers of oxidative stress, inflammation, and placental pathology.

Main Methods:

• Thirty pregnant Sprague-Dawley rats were divided into control, L-NAME induced preeclampsia, and astaxanthin-treated groups.
• L-NAME was administered to induce preeclampsia symptoms, while astaxanthin was given to the treatment group.
• Blood pressure, urine protein, serum oxidative stress markers (MDA, SOD, NOS), and placental tissue expressions of NF-κB, ROCK II, HO-1, and Caspase 3 were analyzed.

Main Results:

• L-NAME administration successfully induced preeclampsia symptoms, including elevated blood pressure and urinary protein.
• Astaxanthin treatment significantly reduced blood pressure (P < 0.01) and malondialdehyde (MDA) levels (P < 0.05), while increasing superoxide dismutase (SOD) activity (P < 0.05).
• Astaxanthin also improved placental histology, reduced inflammatory markers (NF-κB, ROCK II, Caspase 3), and increased antioxidant markers (HO-1).

Conclusions:

• Astaxanthin demonstrates significant efficacy in ameliorating L-NAME induced preeclampsia symptoms in rats.
• The protective effects are attributed to the reduction of oxidative stress and inflammatory damage.
• Astaxanthin holds promise as a potential preventative and therapeutic agent for preeclampsia.